Trebananib (AMG 386)

trebananib · Amgen

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Trebananib (AMG 386), covering 2014-04-29 to 2015-10-14. Get the full timeline:

Most recent: Clinical Trial Update: Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian Cancer [Phase 1]